Nextech Invest
Overview
Nextech Invest is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland, that invests in emerging biotechnology companies developing transformative cancer medicines and precision oncology therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Revolution Medicines | Jul 2019 | Series C | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
| Stipple Bio | Apr 2026 | Series A | Lead |
| Alumis Inc | Mar 2024 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Jakob Loven
Managing Partner
Kanishka Pothula
Managing Partner
Thilo Schroeder
Managing Partner
Melissa McCracken
Partner
Rocco Sgobbo
Partner
Niresh Berinpanathan
Principal
Sarah Soo-Hoo
Principal
Thomas Geninatti
Principal
Daniel Michaeli
Biotech Venture Capital
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Nextech Invest based?
Nextech Invest is headquartered in Zurich, Switzerland.
When was Nextech Invest founded?
Nextech Invest was founded in 1998.
How many portfolio companies does Nextech Invest have?
Nextech Invest has 71 portfolio companies in Caplight's dataset.
What are some companies in Nextech Invest's portfolio?
Portfolio companies visible on Caplight include Revolution Medicines, Parabilis Medicines, Fog Pharmaceuticals, Stipple Bio, Alumis Inc.
What was Nextech Invest's most recent investment shown here?
Nextech Invest's most recent investment in this portfolio sample was in Stipple Bio in 2026.
What sectors does Nextech Invest focus on?
Nextech Invest focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Nextech Invest focus on?
Nextech Invest typically invests at the Mid stage.
What is Nextech Invest's AUM?
Nextech Invest's assets under management are estimated between $500.0M and $1.0B.